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Abstract—Estradiol biosynthesis is catalyzed by the en-
zyme aromatase, the product of the CYP19A1 gene. Aro-
matase is expressed in the brain, where it is involved not
only in the control of neuroendocrine events and reproduc-
tion, but also in the regulation of neural development,
synaptic plasticity and cell survival. In this review we sum-
marize the existing data related with the detection of aro-
matase in human brain, with particular emphasis in the
so-called “non-primary reproductive” areas. Besides hypo-
thalamus, amygdala and preoptic/septal areas, aromatase
is expressed in certain regions of basal forebrain, cerebral
cortex, hippocampus, thalamus, cerebellum and brainstem
of the human brain. Aromatase in human brain is produced
by neurons, but there is also an astrocyte subpopulation
that constitutively expresses the enzyme. The use of dif-
ferent methodological approaches, including the in vivo
analysis by positron emission tomography of human sub-
jects, has permitted to draw a general map of human brain
aromatase, but the detailed distribution map is still far to
be completed. On the other hand, despite the fact that there
is only one aromatase protein, there are multiple mRNA
transcripts that differ in the 5’-untranslated region, where
regulatory elements reside. To date, some of the aroma-
tase transcripts characteristic of cerebral cortex, as well as
of human cell lines of neural origin, have been identified.
This characteristic may confer tissue or even region-spe-
cific regulation of the expression and therefore it is con-
ceivable to develop selective aromatase modulators to reg-
ulate the expression of the enzyme in the human brain.
This article is part of a Special Issue entitled: Neuroac-
tive Steroids: Focus on Human Brain. © 2011 IBRO. Pub-
lished by Elsevier Ltd. All rights reserved.
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Aromatase, the product of CYP19A1 gene, is the enzyme
that synthesizes estrogens from androgen precursors. It is
a cytochrome p450 protein of the family 19A, also known
as P450AROM, estrogen synthase or estrogen synthe-
tase. Fig. 1 depicts the three possible aromatase catalyzed
reactions in which 19 carbon atom precursors are consec-
utively oxidized, hydroxylated and finally demethylated to
render 18 carbon atom estrogens, wearing the character-
istic phenolic ring (Boon et al., 2010). The estrogens pro-
duced in a given tissue depend on the bioavailability of
substrates. In the case of human brain, the three precur-
sors shown in Fig. 1 have been isolated (Schindler, 1975;
Hammond et al., 1983; Milewich et al., 1986).
Aromatase activity or expression has been described in
everal brain regions and different cell types in all verte-
rates, from fish to primates (Callard et al., 1977, 1978;
elmanoff et al., 1977; Steimer and Hutchison, 1980; Ma-
Lusky et al., 1986). Human brain aromatase activity was first
escribed by Naftolin and collaborators in fetal hypothalamus
Naftolin et al., 1971a) and limbic system (Naftolin et al.,
971b). These findings perfectly matched with the role pro-
osed for testosterone and estradiol in brain sex determina-
ion and the control of sex behavior (Harris and Levine, 1965;
estley and Salaman, 1976; McEwen et al., 1977; for re-
iews see Morris et al., 2004; Bakker and Baum, 2008;
right et al., 2010). Thus, the concept of brain regions in-
olved in the central reproductive control emerged. These
egions include the hypothalamus, the preoptic area and the
mygdala. Later on, alternative roles for sex steroids in the
rain were discovered, acting in what it has been called
non-primary brain sex areas”. These new roles of sex hor-
ones in the brain include the regulation of neuronal survival,
he modulation of synaptic function and the control of neuro-
enesis (Azcoitia et al., 2001; Garcia-Segura et al., 2001;
retz et al., 2004; Martinez-Cerdeno et al., 2006; Pawluski et
l., 2009; see Garcia-Segura, 2008; Boon et al., 2010 for
eviews). Moreover, it has also been described scenarios in
hich reproductive and non-reproductive areas converge to
ope with unexpected roles. For instance, estradiol is part of
he hormonal system modulating the amygdala-prefrontal
ortex emotion circuit (Van Wingen, 2011); related to this, it is
orthy to point out that both amygdala neurons (Roselli et al.,
998) and prefrontal cortex astrocytes (Luchetti et al., in





















I. Azcoitia et al. / Neuroscience 191 (2011) 139–147140tal, cardiovascular and adipose tissues, make estrogens key
elements “involved in the maintenance of general physiolog-
ical homeostasis in both sexes” (Simpson and Jones, 2006).
In this review, we will focus mainly in the non-reproduc-
tive sphere of estrogens in brain. We will consider data on
aromatase expression. For functional and gene regulation
data, the reader is referred to recent reviews in the field
(Garcia-Segura, 2008; Roselli et al., 2009; Boon et al., 2010).
AROMATASE EXPRESSION
Brain aromatase has been evidenced by enzyme activity
assays, protein expression (immunocytochemistry, Western
blotting), mRNA expression (in situ hybridization and reverse
transcriptase-polymerase chain reaction) gene transcription
and binding of radioactive labeled inhibitors that generate
positron emission tomography (PET) images. There is
not a complete correlation in the results obtained with
these different techniques, which could be explained in
terms of methodological limitations, but also due to dif-
ferences in stability of the products: for instance, short-
live transcripts that translate into stable protein or vice-
versa; or protein modifications that can hide/expose the
epitope against a particular anti-aromatase antibody.
Enzyme activity assay
One of the most extended assays is the in vitro radiometric
method, based on the release of radioactive water after
supplying radiolabeled (mostly tritiated) androgens to tis-
sue homogenates (Weisz, 1982). This was the method
used by Naftolin in the first descriptions of aromatase
activity in human hypothalamus (Naftolin et al., 1971a) and
limbic system (Naftolin et al., 1971b). Aromatase activity
has been also demonstrated in hippocampus and cerebral
cortex of non-human primates during late fetal and early
postnatal life (MacLusky et al., 1987) and human temporal
cortex from postmortem samples (Wozniak et al., 1998)
and biopsies (Steckelbroeck et al., 1999). Cortical enzyme
activity seems to be unrelated to sex or age differences
(Steckelbroeck et al., 1999). The enzyme assay is also















Fig. 1. Aromatization of precursor androgens by aromatase enzyme
phenolic ring, characteristic of estrogens, in red.human astrocytomas (Weidenfeld and Schiller, 1984). mImmunocytochemistry
Aromatase immunoreactivity in human brain has been
described in hypothalamus, preoptic area and amygdala
(Ishunina et al., 2005). Besides these reproductive brain
centers, aromatase has been localized in cholinergic
basal forebrain (Ishunina et al., 2005) in temporal
(Yague et al., 2006) and prefrontal cortices (Luchetti et
al., in press), as well as in hippocampal formation, in-
cluding both dentate gyrus and Ammon’s horn CA1–CA4
sectors (Ishunina et al., 2007; Yague et al., 2010). Aro-
matase immunoreactivity is reduced in the hippocampus
of Alzheimer disease patients (Ishunina et al., 2007), but
it remains intact in individuals affected by epilepsy
(Yague et al., 2010). On the other hand, a clear increase
in aromatase immunoreactivity has been detected in the
basal forebrain (nucleus basalis of Meynert) during nor-
mal aging (Ishunina et al., 2005). Related to the effect of
circulating estrogens in aromatase expression, there is
not a complete study in humans, but it remains unaltered
in non-human primates hippocampus, comparing intact
versus ovariectomized females (Yague et al., 2008).
his result is in agreement with the data of enzyme
ctivity assay of human biopsies obtained during neu-
osurgical partial resection of the temporal lobe (Steck-
lbroeck et al., 1999, see former subsection).
With respect to cell types, mammalian brain aromatase
s mostly expressed in neurons, but there are also some
mmunoreactive glia cells. Neurons expressing aromatase
n the temporal cortex of human and non-human primates
nd in human hippocampus are both principal (pyramidal
nd dentate granule cells) and different types of interneu-
ons (Yague et al., 2006, 2008, 2010). Neuronal aroma-
ase is present in perikarya, dendrites and axons (Yague et
l., 2006). Aromatase containing axon terminals establish
ynapses with both aromatase immuno-negative and im-
uno-positive dendrites and somata (Naftolin et al., 1996).
stradiol locally produced within the synapse is thought to
egulate synaptogesis (Kretz et al., 2004), neurotransmis-
ion (Balthazart and Ball, 2006) and synaptic plasticity
Mukai et al., 2010; Zhou et al., 2010).
Glia cells expressing aromatase in non-primate
H
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I. Azcoitia et al. / Neuroscience 191 (2011) 139–147 141tia et al., 2003), gliomas (Yague et al., 2004), cortical
progenitor glia (Martinez-Cerdeno et al., 2006), or as-
trocytes in brain areas submitted to different types of
lesion (Garcia-Segura et al., 1999, 2003). Human aro-
matase immunoreactivity in glia has been described in
ependymal cells and choroid plexus ependymal (Is-
hunina et al., 2005), human glioblastoma cell lines
(Yague et al., 2004) and prefrontal and temporal cere-
bral cortices (Yague et al., 2006; Luchetti et al., in
press). Aromatase expression in human hippocampal
glia has been described in astrocytes (Ishunina et al.,
2007; Yague et al., 2010). Interestingly, hippocampal
human astrocytes do not behave as those in other mam-
mals and do not express the enzyme in certain stressful
conditions, such as epilepsy (Yague et al., 2010).
mRNA expression
Besides some few studies in non-human mammals in
which mRNA expression has been demonstrated by in
situ hybridization (Roselli et al., 2001), the main body of
data comes from reverse transcriptase-polymerase
chain reaction (RT-PCR). First PCR descriptions of aro-
matase in human brain came from fetal material (Toda et
al., 1994). In fact, the two key regulatory proteins of
estrogen synthesis, namely the Steroidogenic Acute
Regulatory protein (StAR), placed at the beginning of
the pathway, and aromatase, at the end of the pathway,
have been detected by PCR in human fetal brain (Pezzi
et al., 2003). In adults, different aromatase transcripts
have been found in several brain regions, including
pons, thalamus, hypothalamus and hippocampus, of
both women and men (Sasano et al., 1998). Stoffel-
agner et al. (1998) found aromatase transcription in
uman temporal cortex. No differences between men
nd women have been described in temporal cortex
RNA levels, but there are significantly higher values in














For aromatase expression, examples of several experimental appro
immunocytochemical and mRNA detection methods. Most of the data
chemistry; RT-PCR, reverse transcriptase-polymerase chain reaction
strogen receptor beta. 1: Wozniak et al., 1998; 2: Steckelbroeck et a
l., 1999; 6: Biegon et al., 2010; 7: Osterlund et al., 2000; 8: Ishunina
Swaab, 2008; 12: Ishunina et al., 2005; 13: Ishunina and Swaab, 200
17: Kruijver et al., 2003; 18: Belcher et al., 2009; 19: Weidenfeld and Schiller,dults than in children (Stoffel-Wagner et al., 1998).
ippocampus and to a lesser extent frontal cortex are
lso involved in aromatase transcription (Stoffel-Wagner
t al., 1999). Confirming immunocytochemical analysis,
romatase transcripts have been found in prefrontal
ortex, where quantitative PCR studies showed in-
reased mRNA levels (as much as 2.4-fold higher) in
lzheimer’s disease patients, compared to matched
ontrols (Luchetti et al., in press). In contrast, the hip-
ocampus shows a significant down-regulation in aro-
atase transcripts in Alzheimer’s disease subjects com-
ared to controls (Ishunina et al., 2007). This apparent
iscrepancy could be due to a possible swift neuron-to-
stroglia aromatase expression. As it happens in the
ippocampus, prefrontal cortex neurons from Alzhei-
er’s disease patients show a reduced aromatase tran-
cription, but astrocytes, particularly those in layers 2
nd 3, over-express the enzyme (Luchetti et al., in
ress). The astroglial expression of aromatase may
ompensate for the reduction in neuronal expression
nd even result in a higher global value. In the case of
he hippocampal formation, the drop in aromatase neu-
onal transcription cannot be compensated, probably
ecause human hippocampal astrocytes do not synthe-
ize aromatase, either in normal or stress conditions, as
fficiently as cortical astrocytes do (see at the end of the
ormer sub-section).
Human CYP19A1 gene consists of nine coding exons
nd a 5’- unstranslated region, containing alternative pro-
oter and untranslated first exons. To date, 11 different
rst exons have been reported in human aromatase (Boon
t al., 2010) that may confer tissue-specific regulation of its
xpression. Sasano et al. (1998) identified the so-called
rain transcript 1f, plus 1b and 1d transcripts [correspond-
ng respectively to 1.4 and PII in Simpson’s nomenclature
Boon et al., 2010)]. Yague et al. (2006) confirmed the use
n in human brain
Aromatase
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re presented, while estrogen receptor expression is mainly based on
ed on adult subjects. EAA, enzyme activity assay; ICC, immunocyto-
ositron emission tomography; ER, estrogen receptor alpha; ER,
3: Luchetti et al., in press; 4: Yague et al., 2006; 5: Stoffel-Wagner et
07; 9: Yague et al., 2010; 10: Sasano et al., 1998; 11: Ishunina and













1984; 20: Yague et al., 2004.
I. Azcoitia et al. / Neuroscience 191 (2011) 139–147142of exons I.f, I.4 and PII and described also the exon I.3T
(the truncated form of I.3) in human temporal cortex. They
also analyzed aromatase transcription in the human cell
lines glioblastoma multiforme T98G, glioblastoma-astrocy-
toma U373 and neuroblastoma SHSY5Y (Yague et al.,
2004, 2006), confirming that all these cell lines transcribe
aromatase. They use the same promoters identified in
temporal cortex, that is, PII, I.3T, I.f and I.4 and a new one,
the I.7 exon that could be a signature of transformed neural
Fig. 2. Aromatase expression in cerebral cortex and hippocampus. A
layers 1–6 and in white matter (wm). Panel (B) depicts some pyramid
cortical pyramidal cells also express aromatase (C), but mainly restricte
hilar interneurons (H), are aromatase immunoreactive. A similar patte
few granular and hilar neurons are aromatase positive. CA1, sector 1 o
dentate molecular layer. Scale bars: (A)300 m; (B, C, E, H)100 m; (G, Fcells. The list of aromatase promoter exons seems not
having an end, and recently it has been described the exon
I.8, which makes the 11th in its class (Demura et al., 2008).
Expression of this exon was extremely low in fetal human
brain, but acquires certain significance in adults.
The mechanisms and factors that regulate the activ-
ity of the different promoters in the aromatase gene in
the human brain need to be systematically explored.
This will allow a selective regulation of aromatase ex-
e expressing cells appear through the entire human cortex (A), from
n which aromatase is distributed in perikarya and processes. Rodent
r 5. In human hippocampus, pyramidal cells (D), granular cells (F) and
seen in rodent Ammon’s horn (E), but in dentate gyrus (G) only very




f Cornu A)50 m; (D)200 m.
I. Azcoitia et al. / Neuroscience 191 (2011) 139–147 143pression in different brain regions. In this aspect, there
are already some data on aromatase transcription reg-
ulation in human glioma and neuroblastoma cell lines
(Yague et al., 2009).
Positron emission tomography (PET) imaging
Brain aromatase can be evidenced in vivo by the use of
radiolabeled inhibitors of the enzyme that specifically bind
to it, allowing the analysis of aromatase distribution based
on PET studies. Aromatase inhibitor election is critical and
certain third-generation inhibitors, such as letrozole that
are currently used in clinics due to their high inhibitory
activity, are not the most efficient, because of their rela-
tively low affinity (Kil et al., 2009). Vorozole, a second
generation inhibitor with a higher affinity (close to 15 fold),
seems more appropriate for the analysis of brain aroma-
tase distribution (Takahashi et al., 2006). Recently, Biegon
et al. (2010) administered [N-methyl-11C] vorozole to six
young, healthy voluntaries, three men and three women
and observed the brain distribution of the radiotracer. They
found that the higher content of aromatase was in thala-
Fig. 3. Aromatase expression in human cortical astrocytes. Colocaliza
matter associated to cerebral cortex. Most of the astrocytes in white m
matter (B), there are colocalizing cells (arrows), GFAP expressing
morphologically resembling astrocytes (white arrowheads). Similarly
aromatase and GFAP (arrows); the most do not express the enzy
(arrowhead). Scale bars: (A)50 m; (B, C)100 m.mus, followed by amygdala, preoptic area and medulla
oblongata. There was also a significant binding in temporal
and occipital cortices, basal ganglia, cerebellum, pons and
white matter.
BRAIN ESTROGEN BIOSYNTHESIS IN THE
HUMAN BRAIN: TO WHAT EXTENT?
Comparing the heterogeneity in results obtained in differ-
ent studies, the question is to determine how generalized
is estrogen synthesis within the human brain. Is estrogen
production only efficient when in large amounts, as in the
hypothalamus, or even minute and extremely localized
estrogen production matters, as it could be the case for
synaptic plasticity modulation? Is the synthesis a sustained
episode or rather a series of short events that could be
misinterpreted as artifacts? Generally speaking, some mo-
lecular biology approaches, show a much restricted aro-
matase distribution than immunological methods, PCR,
enzyme activity assays or PET. In a gene expression study
in mouse with engineered aromatase co-expressing two
reporter genes, positive signal was only found in preoptic
FAP and aromatase can be seen in superficial (A) and deep (B) white
e to cortical layer 6 (A) colocalize both proteins, while in deeper white
trocytes (black arrowheads) and aromatase only expressing cells
fraction of interlaminar astrocytes of cortical layer 1 (C) colocalizes





































I. Azcoitia et al. / Neuroscience 191 (2011) 139–147144area, hypothalamus and amygdala (Wu et al., 2009). Sim-
ilar results have been obtained by in situ hibrydization
studies (http://www.ncbi.nlm.nih.gov/gensat, Cyp19a1),
but other molecular biology techniques, such as RT-PCR
(Munetsuna et al., 2009), immunocytochemistry (Hojo et
al., 2004), enzyme activity assays (Konkle and McCarthy,
2011), or PET images (Takahashi et al., 2006) confirm that
aromatase is also present in many other brain areas. The
generalized expression of aromatase can also be inferred
by the fact that these mentioned areas accumulate estra-
diol, as measured by liquid chromatography followed by
tandem mass spectrometry (Konkle and McCarthy, 2011).
Furthermore, cerebral inhibition of aromatase, abolish
brain-specific estrogen actions, such as hippocampal neu-
roprotection (Azcoitia et al., 2001), olfactory bulb neuro-
genesis (Veyrac and Bakker, in press), neuron survival
(Hill et al., 2009), reduced reeelin expression in Cajal-
Retzius cells (Bender et al., 2010) or vestibular nuclei
long-term potentiation (Grassi et al., 2009). To conclude, it
is worthy to note that there is a positive correlation be-
tween aromatase expression and estrogen receptors dis-
tribution (Gillies and McArthur, 2010). This correlation is
shown in Table 1 that summarizes the main findings on
romatase and estrogen receptors distribution in human
rain.
The difficulties to obtain postmortem human material in
ppropriate conditions for the analysis is a limiting factor
or a complete study of the areas implicated in estrogen
Fig. 4. Aromatase expression in cerebellum and thalamus. Human ce
rons (arrows), but not in granular cells (A), while in mouse cerebellum,
expressing aromatase in diencephalon, such as thalamic reticular nuc
m.roduction. Trying to reproduce in the human brain the
esults obtained in lower mammals can be a good start. In
his regard, after finding aromatase immunoreactive neu-
ons in cerebral cortex and hippocampus in rodents, we
rocessed human cortex and hippocampus confirming that
hese areas were also aromatase positive in humans. In-
eed, immunoreactivity is more generalized in human
rain: as it is shown in Fig. 2, aromatase is mainly re-
tricted to pyramidal neurons in layer V in rodent’s cortex,
hile in humans aromatase positive neurons are both
yramidal cells and interneurons, distributed through all
ortical strata. Similarly, in rodent hippocampus the stain-
ng is particularly intense in apical dendrites of CA pyrami-
al cells but restricted to few granular cells, while in hu-
ans, CA cell bodies and most of the granular cells are
mmunopositive (Fig. 2). Special mention deserves glia: in
on-primate brain, aromatase immunoreactive astrocytes
re absent, unless a lesion had been induced, while in
uman brain, there are astrocytes that constitutively ex-
ress the enzyme. For instance, some interlaminar astro-
ytes (Fig. 3), a subclass exclusive of primates that local-
ze at cortical layer 1 (Oberheim et al., 2009), express
romatase, as do some astrocytes in deeper layers and in
he white matter. These astrocytes are only a small fraction
f the total astroglia population, and interestingly, some
ells morphologically identical to astrocytes that do not
xpress GFAP, are aromatase immunoreactive (Fig. 3).
ther glial cell types can be involved in estrogen synthesis;
expresses aromatase in Purkinje cells and molecular layer interneu-
kinje cells are immunoreactive (B). There are also several cell groups
























I. Azcoitia et al. / Neuroscience 191 (2011) 139–147 145aromatase immunoreactive ependymal and subependy-
mal cells detected in rodents have been also described in
humans (Ishunina et al., 2005).
Aromatase expression in rodent cerebellum and thal-
amus is also observed in human brain. In mouse cerebel-
lum, only Purkinje cells are immunoreactive, while in hu-
mans the staining is observed in Purkinje cells and in
interneurons (Fig. 4). With respect to the thalamus, several
nuclei express aromatase in rodents, being reticular nu-
cleus one of the deepest stained. Once again, human
thalamus exhibits a corresponding immunoreactivity (Fig.
4) that perfectly matches with PET observations (Biegon et
al., 2010). Finally, the high level of [N-methyl-11C] voro-
zole binding by inferior olivary complex observed in hu-
mans perfectly fits with the enhanced neurodegeneration
in rat inferior olive after aromatase inhibition in an experi-
mental lesion model (Sierra et al., 2003).
CONCLUSION
Local estradiol synthesis in the human brain seems to be a
more extended phenomenon than initially supposed. How-
ever, a detailed map of the human brain regions express-
ing aromatase is still missing. It is also unknown whether
different promoters of the aromatase gene are used in
different brain regions to regulate aromatase expression.
The use of non-invasive in vivo techniques of determina-
tion paralleled with the systematic study of aromatase
expression in postmortem brain or brain biopsies is a
mandatory first step to conduct thereafter a systematic
RT-PCR analysis of the different transcripts of aromatase
mRNA in different brain regions. At the same time, the
mechanisms and factors that regulate the activity of the
different promoters in the aromatase gene in the human
brain need to be explored.
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